Literature DB >> 12419794

Multidrug-resistant MCF-7 cells: an identity crisis?

Kapil Mehta, Eswaran Devarajan, Jack Chen, Asha Multani, Sen Pathak.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12419794     DOI： 10.1093/jnci/94.21.1652-b

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  16 in total

1.  Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.

Authors:  Yong-Yu Liu; Gauri A Patwardhan; Kaustubh Bhinge; Vineet Gupta; Xin Gu; S Michal Jazwinski
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

2.  Identification of CD44 as a surface biomarker for drug resistance by surface proteome signature technology.

Authors:  Jason W Cain; Robert S Hauptschein; Jean K Stewart; Tugba Bagci; Gary G Sahagian; Daniel G Jay
Journal:  Mol Cancer Res       Date:  2011-02-25       Impact factor: 5.852

3.  MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research.

Authors:  Weifeng Ke; Pei Yu; Jianfeng Wang; Ruitao Wang; Chongyong Guo; Ling Zhou; Changchun Li; Ke Li
Journal:  Med Oncol       Date:  2010-11-30       Impact factor: 3.064

4.  Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.

Authors:  Yong-Yu Liu; Vineet Gupta; Gauri A Patwardhan; Kaustubh Bhinge; Yunfeng Zhao; Jianxiong Bao; Harihara Mehendale; Myles C Cabot; Yu-Teh Li; S Michal Jazwinski
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

5.  Tissue transgluaminase 2 expression in meningiomas.

Authors:  Liya Yuan; Amir Behdad; Matthew Siegel; Chaitan Khosla; Ryuji Higashikubo; Keith M Rich
Journal:  J Neurooncol       Date:  2008-06-28       Impact factor: 4.130

6.  Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance.

Authors:  Eun Seong Lee; Zhonggao Gao; Dongin Kim; Kyeongsoon Park; Ick Chan Kwon; You Han Bae
Journal:  J Control Release       Date:  2008-05-09       Impact factor: 9.776

7.  The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.

Authors:  Ning Zhang; Xiaolong Wang; Qiang Huo; Xiaoyan Li; Huiyun Wang; Pascal Schneider; Guohong Hu; Qifeng Yang
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

8.  Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.

Authors:  Xin Zheng; Fei Chu; Pauline M Chou; Christine Gallati; Usawadee Dier; Bernard L Mirkin; Shaker A Mousa; Abdelhadi Rebbaa
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-29       Impact factor: 4.249

9.  Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells.

Authors:  Mark Kester; Yasser Heakal; Todd Fox; Arati Sharma; Gavin P Robertson; Thomas T Morgan; Erhan I Altinoğlu; Amra Tabaković; Mylisa R Parette; Sarah M Rouse; Victor Ruiz-Velasco; James H Adair
Journal:  Nano Lett       Date:  2008-12       Impact factor: 11.189

10.  A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis.

Authors:  Gauri A Patwardhan; Qian-Jin Zhang; Dongmei Yin; Vineet Gupta; Jianxiong Bao; Can E Senkal; Besim Ogretmen; Myles C Cabot; Girish V Shah; Paul W Sylvester; S Michal Jazwinski; Yong-Yu Liu
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.